Following recent constructive FDA feedback, Seres anticipates finalizing SER-155 Phase 2 study protocol for the prevention of bloodstream infections in adults undergoing allogeneic hematopoietic stem ...
Following Federal Railroad Administration (FRA) approval in April and launch of Phase 1 in June, Parallel Systems, in partnership with Genesee & Wyoming (G&W), has transitioned to Phase 2 of its first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback